FDA Approves New Vaccine To Prevent Gastroenteritis Caused By Rotavirus

The U.S. Food and Drug Administration announced the approval of Rotarix, the second oral U.S. licensed vaccine for the prevention of rotavirus, an infection that causes gastroenteritis (vomiting and diarrhea) in infants and children. Rotarix is a liquid and given in a two-dose series to infants from 6 to 24 weeks of age. Although the disease is usually self-limiting, rotavirus causes about 2.7 million cases of gastroenteritis in U.S.

More: continued here

Filed under: GastroIntestinal / Gastroentorology on April 4th, 2008